Antioxidative Capacity of Wine on Human LDL Oxidation in Vitro: Effect of Skin Contact in Winemaking of White Wine

Journal of Agricultural and Food Chemistry

Volumn 45, Issue 4, 1997, Pages 1283-1289

  Hurtado, Isabel ^a   Caldú, Pilar ^a   Gonzalo, Albert ^c   Ramon, Josep M ^b   Mínguez, Santiago ^c   Fiol, Concepció ^a  

^a Servei de Medicina Preventiva   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c GENERALITAT DE CATALUNYA   (Spain)

Author keywords

Atherosclerosis; Lipoprotein peroxidation; Polyphenols; Wine extracts

Indexed keywords

VITIS SP.;

EID: 0000193559     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf960583p     Document Type: Article

References (50)

1. Boulton, R. B.; Singleton, V. L.; Bisson, L. F.; Kunkee, R. E. Preparation of must and juice. In Principles and practices of winemaking; Thomson Publishing: New York, 1995; pp 65-101.
2. Bowry, V. W.; Stanley, K. K.; Stocker, R. High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors. Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 10316-10320.
3. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
4. Brown, M. S.; Goldstein, J. L. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu. Rev. Biochem. 1983, 52, 223-261.
5. Caldú, P.; Hurtado, I.; Gonzalo, A.; et al. White wine reduces the susceptibility of low-density lipoprotein to oxidation (letter). Am. J. Clin. Nutr. 1996, 63, 403.
6. Camargo, C. A.; Williams, P. T.; Vranizan, K. M.; Albers, J. J.; Wood, P. D. The effect of moderate alcohol intake on serum apolipoproteins A-I and A-II. JAMA 1985, 253, 2854-2857.
7. Das, N. P. Studies on flavonoid metabolism: Absorption and metabolism of catechin in man. Biochem. Pharmacol. 1971, 20, 3435-3445.
8. De Rijke, Y. B.; Demacker, P. N. M.; Assen, N. A.; Sloots, L. M.; Katan, M. B.; Stalenhoef, A. F. H. Red wine consumption does not affect oxidizability of low-density lipoproteins in volunteers. Am. J. Clin. Nutr. 1996, 63, 329-334.
9. De Whalley, C. V.; Rankin, S. M.; Hault, J. R. S.; et al. Flavonoids inhibit the oxidative modification of low-density lipoprotein by macrophages. Biochem. Pharmacol. 1990, 39, 1743-1750.
10. ERICA Research Group. The CHD risk-map of Europe: The first report of the WHO-ERICA project. Eur. Heart J. 1988, 9 (Suppl. 1), 1-36.
11. Esterbauer, H.; Striegl, G.; Puhl, H.; Rotheneder, M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radical Res. Commun. 1989, 6, 67-75.
12. Esterbauer, H.; Dieber-Rotheneder, M.; Waeg, G.; Striegl, G.; Jürgens, G. Biochemical, structural and functional properties of oxidized low-density lipoprotein. Chem. Res. Toxicol. 1990, 3, 77-92.
13. Esterbauer, H.; Gebicki, J.; Puhl, H.; Jürgens, G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radicals Biol. Med. 1992, 13, 341-381.
14. Frankel, E. N.; Kanner, J.; German, J. B.; et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993a, 341, 454-457.
15. Frankel, E. N.; Waterhouse, A. L.; Kinsella, J. E. Inhibition of human LDL oxidation by resveratrol. Lancet 1993b, 341, 1103-1104.
16. Frankel, E. N.; Waterhouse, A. L.; Teissedre, P. L. Principal phenolic phytochemicals in selected California wines and their antioxidant activity in inhibiting oxidation of human low-density lipoproteins. J. Agric. Food Chem. 1995, 43, 890-894.
17. Fuhrman, B.; Lavy, A.; Aviram, M. Consumption of red wine with meals reduces the susceptibility of human plasma and low-density lipoprotein to lipid peroxidation. Am. J. Clin. Nutr. 1995, 61, 549-554.
18. Fumeron, F.; Betouelle, D.; Luc, G.; et al. Alcohol intake modulates the effect of polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 1995, 96, 1664-1671.
19. Gebicki, J. M.; Jürgens, G.; Esterbauer, H. Oxidation of low-density lipoprotein in vitro. In Oxidative stress: Oxidants and antioxidants; Sies, H., Ed.; Academic Press Inc.: New York, 1991; pp 371-379.
20. Griffith, L. A. Mammalian metabolism of flavonoids. In The flavonoids: Advances in research; Harborne, J. B., Mabry, T. J., Eds.; London: Chapman and Hall: London, 1982; pp 681-718.
21. Gugler, R.; Leschik, M.; Dengler, H. J. Deposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 1975, 9, 229-234.
22. Haberland, M. E.; Fogelman, A. M.; Edwards, P. A. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 1712-1716.
23. 14C]cyanidanol-3 in man following oral administration. Xenobiotica 1983, 13, 279-283.
24. Hannuksela, M. L.; Rautala, M.; Kesaniemi, Y. A.; Savolaien, M. J. Ethanol-induced redistribution of cholesteryl ester transfer protein (CETP) between lipoproteins. Arterioscler. Thromb. Vasc. Biol. 1996, 16, 213-221.
25. Hatch, F. T.; Lees, E. S. Practical methods for plasma lipoprotein analysis. Adv. Lipid Res. 1968, 6, 1-68.
26. Havel, R. J.; Eder, H. A.; Bragdon, J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 1959, 34, 1345-1353.
27. Hegsted, D. M.; Ausman, L. M. Diet, alcohol and coronary heart disease in man. Am. J. Clin. Nutr. 1988, 118, 1184-1189.
28. Jackson, R.; Beaglehole, R. The relation between alcohol and coronary disease: Is there a protective effect? Curr. Opin. Lipidol. 1993, 4, 21-26.
29. Kanner, J.; Frankel, E. N.; Granit, R.; German, B.; Kinsella, J. E. Natural antioxidants in grapes and wines. J. Agric. Food. Chem. 1994, 42, 64-69.
30. Keys, A. Coronary heart disease in seven countries. Circulation 1970, 41 (Suppl. 1), 163-211.
31. Kleinveld, H. A.; Hak-Lemmers, H. L. M.; Stalenhoef, A. F. H.; Demacker, P. N. M. Improved measurement of low-density lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein. Clin. Chem. 1992, 38 (10), 2066-2072.
32. Kondo, K.; Matsumoto, A.; Kurata, H.; et al. Inhibition of oxidation of low-density lipoprotein with red wine (letter). Lancet 1994, 344, 1152.
33. Masana, L.; Camprubí, M.; Sardà, P.; et al. The Mediterranean type diet: Is there a need for further modification? Am. J. Clin. Nutr. 1991, 53, 886-889.
34. Meade, T. W.; Mellows, S.; Brozovic, M.; et al. Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park Heart Study. Lancet 1986, 2, 533-37.
35. Moore, R. D.; Pearson, T. A. Moderate alcohol consumption and coronary artery disease. A review. Medicine 1986, 65, 242-267.
36. Muller, C. J.; Fugelsang, K. C. Take two glasses of wine and see me in the morning (letter). Lancet 1994, 343, 1428.
37. National Research Council Committee on Diet and Health. Diet and Health: Implications for reducing chronic disease risk; National Academy Press: Washington, DC, 1989.
38. Office International de la Vigne et du Vin. Recueil des méthodes internationales d'analyse des vins et des mouts; Edition Officielle: Paris, 1990.
39. Parthasarathy, S.; Rankin, S. M. Role of oxidized low density lipoproteins in atherogenesis. Prog. Lipid Res. 1992, 31, 127-143.
40. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339, 1523-1526.
41. Rimm, E. B.; Giovannucci, F. L.; Willett, W. C.; et al. Prospective study of alcohol consumption and risk of coronary heart disease in men. Lancet 1991, 338, 464-468.
42. Ross, R. The pathogenesis of atherosclerosis: A perspective for 1990s. Nature 1993, 362, 801-809.
43. Serafini, M.; Ghiselli, A.; Ferro-Luzzi, A. Red wine, tea and antioxidants (letter). Lancet 1994, 344, 626.
44. Sharpe, P. C.; McGrath, L. T.; McClean, E.; Young, I. S.; Archbold, G. P. R. Effect of red wine consumption on lipoprotein(a) and other risk factors for atherosclerosis. Q. J. Med. 1995, 61, 549-554.
45. Sims, C. A.; Bates, R. P. Effects of skin fermentation on the phenols, anthocyanins, ellagic acid sediment, and densory characteristics of a red Vitsi rotundifolia wine. Am. J. Enol. Vitic. 1994, 45, 56-62.
46. Stephens, N. G.; Parsons, A.; Schofield, P. M.; Kelly, F.; Cheeseman, K.; Mitchinson, M. J.; et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996, 347, 781-786.
47. Tsen, C. C. An improved spectrophotometric method for determination of tocopherols using 4,7-diphenyl-1,10-phenanthroline. Anal. Chem. 1961, 33, 849-851.
48. Tsuchida, M.; Miura, T.; Mizutani, K.; Aibara, K. Fluorescent substances in mouse and human sera as a parameter of in vivo lipid peroxidation. Biochim. Biophys. Acta 1985, 834, 196-204.
49. Witzum, J. L.; Steinberg, D. Role of oxidized low density lipoprotein in atherogenesis. Clin. Invest. 1991, 88, 1785-1792.
50. Yagi, K. A simple fluorimetric analysis for lipoperoxides in blood plasma. Biochem. Med. 1976, 15, 212-216.